---
figid: PMC9413272__fphar-13-920336-g002
figtitle: Licensing of Orphan Medicinal Products—Use of Real-World Data and Other
  External Data on Efficacy Aspects in Marketing Authorization Applications Concluded
  at the European Medicines Agency Between 2019 and 2021
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9413272
filename: fphar-13-920336-g002.jpg
figlink: /pmc/articles/PMC9413272/figure/F2/
number: F2
caption: 'Flow-chart on the regulatory pathway of the sample of ODs assessed for the
  present analysis. CHMP: Committee for Medicinal Products for Human use; COMP: Committee
  for Orphan Medicinal products; EPAR: European public assessment report; MA(A): marketing
  authorization (application), MP: medicinal product; OD: orphan designation; OMAR:
  orphan maintenance report; OMP: orphan medicinal product; SB: significant benefit.'
papertitle: Licensing of Orphan Medicinal Products—Use of Real-World Data and Other
  External Data on Efficacy Aspects in Marketing Authorization Applications Concluded
  at the European Medicines Agency Between 2019 and 2021.
reftext: Frauke Naumann-Winter, et al. Front Pharmacol. 2022;13:920336.
year: '2022'
doi: 10.3389/fphar.2022.920336
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: real-world data | drug development | orphan medicinal product | orphan drugs
  | efficacy | marketing authorization application
automl_pathway: 0.5844145
figid_alias: PMC9413272__F2
figtype: Figure
redirect_from: /figures/PMC9413272__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9413272__fphar-13-920336-g002.html
  '@type': Dataset
  description: 'Flow-chart on the regulatory pathway of the sample of ODs assessed
    for the present analysis. CHMP: Committee for Medicinal Products for Human use;
    COMP: Committee for Orphan Medicinal products; EPAR: European public assessment
    report; MA(A): marketing authorization (application), MP: medicinal product; OD:
    orphan designation; OMAR: orphan maintenance report; OMP: orphan medicinal product;
    SB: significant benefit.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - odd
  - Sb
  - opm
  - Mp
  - 'On'
  - Omar
  - thi
  - thiv
---
